Dr. Jayant Kumar

Acknowledged as an innovator by the Scientific Committee of the All India Ophthalmic Society, Dr. Kumar has been invited multiple times to deliver talks on his groundbreaking innovations. During his six-year tenure at the retina department of Aravind Eye Hospital, Madurai, he had valuable learning opportunities and played a crucial role in the team that internationally published and recognized a novel retinal surgical technique called ‘The Mega Weiss Ring.’

Dr. Kumar was honored with the Best Video Award at Retina Summit 2018 organized by Shankar Netralaya, Chennai. He has consistently been a finalist in various paper and video presentations at national and international conferences. Over the past two years, he has served as a national faculty and actively engages in training young retina surgeons across the country through instruction courses. His recent role as Chief Instructor received acclaim from numerous eminent national faculties.

Professional Experience:

– 2005-2011: MBBS from Government Medical College and Hospital, Nagpur
– 2012-2015: MS Ophthalmology from Regional Institute of Ophthalmology, Kolkata
– 2015-2017: Long-term Vitreo-retina Fellowship at Aravind Eye Hospital, Madurai
– 2017-2021: Vitreo-retina Consultant, Aravind Eye Hospital, Madurai
– 2021 – November 2022: Vitreo-retina Consultant, ASG Eye Hospital, Jamshedpur
– November 2022 – Present: Vitreo-retina Consultant, ASG Eye Hospital, Ranchi

Expertise:

– Retinal detachment
– Advanced Diabetic retinopathy
– Complex tractional retinal detachment
– Macular pathologies like Macular hole, Vitreomacular traction, and ERM
– Scleral fixated Lens implantation
– Complicated Cataract cases like phacoemulsification in Subluxated Cataract with CTR
– Premium (Multifocal, EDOF) and Toric IOL implantation
– Medical retina including Retinopathy of Prematurity (ROP)
– Uveitis

Publications:

Dr. Kumar has authored more than 25 national and international publications, including an international article on retinal manifestations of Covid-19, as well as the world’s largest series on some forms of ocular trauma. His works have been cited more than 60 times internationally, and he played a key role in the development of critical new drugs for eye treatment through multiple drug trials.